FORMULATION AND EVALUATION OF LEVITIRACETAM MATRIX TABLETS

Journal Title: Indo American Journal of Pharmaceutical Sciences - Year 2018, Vol 5, Issue 3

Abstract

For many years the treatment of acute or chronic sicknesses were carried out normally via the transport of medication to sufferers through diverse pharmaceutical forms encompass pills, pills, creams, suppositories, drinks, ointments, aerosols and injectables. The kinds conventional oral drug delivery systems are regarded to provide delivery of the drug. Therefore to reap as well as to hold the drug awareness within the range of healing effectiveness required for the treatment. Levetiracetam matrix tablets were prepared by using different viscosity grades of Polyethylene oxides such as PEO WSR 301, PEO Coagulant and PEO 303. The matrix tablets were prepared by direct compression method. The matrix tablet formulation L-8 and L-10 which releases all the drugs in 12 hours were selected for the study of accelerated stability. All levetiracetam matrix tablets with PEO WSR 301 (L1 to L-4) were evaluated The hardness of the tablets is in the range of 13.1-14 kg/cm2. The friability below 1% indicates clearly the good mechanical resistance of the preparations of tablets. Testing of the prepared matrix tablets was found in the range of 99.1 to 101 % clearly indicates a good uniformity of content. The thickness of the tablets is in the range of 6.18 to 6.28 mm. The weight variation of tablets was within the range and 850 mg were found in all of the tablets. The matrix tablet formulation L-8 and L-10 which releases all the drugs in 12 hours were selected for the study of accelerated stability. DSC and FTIR studies were also performed. Keywords: Controlled release formulations, Levetiracetam matrix tablets, Polyethylene oxides.

Authors and Affiliations

Keywords

Related Articles

FORMULATION, OPTIMIZATION AND EVALUATION COLON TARGATED DRUG DELIVERY SYSTEM FOR ORNIADAZOLE

The colon is a site where both local and systemic delivery of drugs can take place. The present investigation concerns with formulation and evaluation of Colon Targeted dip coated tablets of Ornidazole by using HPMCK4 M,...

ESTIMATION OF ENTECAVIR IN PURE AND PHARMACEUTICAL FORMULATION BY USING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

A rapid and precise Reverse Phase High Performance Liquid Chromatographic method has been developed for the validated of Entecavir, in its pure form as well as in tablet dosage form. Chromatography was carried out on a P...

AFTER ACUTE MYOCARDIAL INFARCTION END RESULT OF CARDIOGENIC SHOCK IN HOSPITALIZED PATIENTS

Purpose: To investigate the in-hospital outcome of cardiogenic shock (CS) after acute myocardial infarction (AMI). Materials and methods: This descriptive study was conducted at the Ch. Parvaiz Elahi Institute of cardiol...

ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF ZALEPLON IN PURE AND TABLET FORMULATION

A rapid and precise Reverse Phase High Performance Liquid Chromatographic method has been developed for the validated of Zaleplon in its pure form as well as in tablet dosage form. Chromatography was carried out on XBrid...

RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF ALOGLIPTIN BULK AND TABLET DOSAGE FORM

This present study reports, a simple, specific, accurate and validated Reverse Phase-Rapid Resolution Liquid Chromatography for identification of Alogliptin. The method employed Inertsil Extend C18 (250 × 4.6 mm, packed...

Download PDF file
  • EP ID EP269933
  • DOI -
  • Views 320
  • Downloads 0

How To Cite

(2018). FORMULATION AND EVALUATION OF LEVITIRACETAM MATRIX TABLETS. Indo American Journal of Pharmaceutical Sciences, 5(3), 1425-1433. https://europub.co.uk/articles/-A-269933